TradingMarkets’ 10 Stocks You Need To Know About This Morning

Monsanto
(
MON |
Quote |
Chart |
News |
PowerRating)
may benefit from less resistance to its genetically
altered seeds, says Barron’s.

Kimberly Clark
(
KMB |
Quote |
Chart |
News |
PowerRating)
guided in-line, said it would buy back $1
billion in shares, and increased its dividend.

Navistar
(
NAV |
Quote |
Chart |
News |
PowerRating)
boosted its Q4 outlook.

Circuit City
(
CC |
Quote |
Chart |
News |
PowerRating)
said same store sales fell 4.3%; expectations
were +2.6%.

Celgene
(
CELG |
Quote |
Chart |
News |
PowerRating)
reported positive data for several studies.

Corgentech
(
CGTK |
Quote |
Chart |
News |
PowerRating)
is lower after an experimental product failed a
late stage trial. Bristol Myers
(
BMY |
Quote |
Chart |
News |
PowerRating)
is also involved in this trial.

Callaway Golf
(
ELY |
Quote |
Chart |
News |
PowerRating)
was mentioned positively in Barron’s.

Unocal
(
UCL |
Quote |
Chart |
News |
PowerRating)
said its board authorized a $465 million buyback.

Barron’s said Cato Corp.
(
CATO |
Quote |
Chart |
News |
PowerRating)
may be undervalued.